Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ERF
3151
DELISTED
Enerplus Corporation
ERF
| $2.92M | ﹤0.01% |
1,032,746
-568,082
| -35% | -$1.44M |
|
3152
S&T Bancorp
STBA
$1.82B
| $2.92M | ﹤0.01% |
124,527
-9,586
| -7% | -$232K |
|
3153
Akebia Therapeutics
AKBA
$256M
| $2.91M | ﹤0.01% |
214,622
+37,240
| +21% | +$385K |
|
3154
Invesco Dorsey Wright Utilities Momentum ETF
PUI
$54.2M
| $2.91M | ﹤0.01% |
99,394
-71,512
| -42% | -$2.16M |
|
3155
Nuveen Real Asset Income & Growth Fund
JRI
$347M
| $2.91M | ﹤0.01% |
248,828
-17,364
| -7% | -$193K |
|
|
NQP
3156
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
| $2.9M | ﹤0.01% |
214,043
+3,587
| +2% | +$47.4K |
|
3157
Invesco S&P MidCap 400 Pure Value ETF
RFV
$336M
| $2.9M | ﹤0.01% |
57,564
+11,279
| +24% | +$529K |
|
|
AAMI
3158
Acadian Asset Management
AAMI
$3.26B
| $2.9M | ﹤0.01% |
233,059
+217,625
| +1,410% | +$1.78M |
|
|
CRHM
3159
DELISTED
CRH Medical Corporation
CRHM
| $2.9M | ﹤0.01% |
1,402,345
-1,518,000
| -52% | -$3.07M |
|
|
CIZ
3160
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
| $2.9M | ﹤0.01% |
107,884
+23,177
| +27% | +$604K |
|
|
APHA
3161
DELISTED
Aphria Inc. Common Shares
APHA
| $2.9M | ﹤0.01% |
676,250
-146,256
| -18% | -$561K |
|
3162
Coca-Cola Femsa
KOF
$23B
| $2.9M | ﹤0.01% |
66,038
-28,899
| -30% | -$1.22M |
|
3163
Invesco Food & Beverage ETF
PBJ
$107M
| $2.9M | ﹤0.01% |
92,697
+3,276
| +4% | +$99.9K |
|
|
INN
3164
Summit Hotel Properties
INN
$724M
| $2.89M | ﹤0.01% |
488,000
-20,624
| -4% | -$116K |
|
|
AIF
3165
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $2.89M | ﹤0.01% |
232,533
+2,169
| +0.9% | +$25.7K |
|
|
ARNA
3166
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.88M | ﹤0.01% |
45,780
+13,051
| +40% | +$718K |
|
3167
Helix Energy Solutions
HLX
$1.45B
| $2.88M | ﹤0.01% |
830,518
+135,824
| +20% | +$367K |
|
3168
Avantor
AVTR
$8.91B
| $2.88M | ﹤0.01% |
169,473
+138,320
| +444% | +$2.25M |
|
3169
SiriusPoint
SPNT
$2.75B
| $2.88M | ﹤0.01% |
383,283
+10,292
| +3% | +$77.7K |
|
|
NMY
3170
DELISTED
Nuveen Maryland Quality Municipal Income Fund
NMY
| $2.87M | ﹤0.01% |
223,098
-45,191
| -17% | -$563K |
|
3171
Principal Exchange-Traded Funds Principal US Small-Cap ETF
PSC
$2.28B
| $2.87M | ﹤0.01% |
105,093
-85,412
| -45% | -$2.16M |
|
|
UCTT
3172
Ultra Clean Holdings
UCTT
$3.76B
| $2.87M | ﹤0.01% |
126,856
-107,203
| -46% | -$2.04M |
|
3173
Prospect Capital
PSEC
$1.11B
| $2.87M | ﹤0.01% |
561,163
-261,012
| -32% | -$1.22M |
|
3174
Lantheus
LNTH
$6.6B
| $2.87M | ﹤0.01% |
200,437
+42,316
| +27% | +$559K |
|
3175
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$716M
| $2.86M | ﹤0.01% |
34,282
+13,435
| +64% | +$1.11M |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,644 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.